Belite Bio Announces Positive Interim Analysis for Phase 3 DRAGON Trial of Tinlarebant in Adolescent Stargardt Disease Patients
14/5 03:10
Belite Bio announced interim analysis results for Tinlarebant in STGD1, recommending trial continuation and regulatory submission....